Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America
Basavaraj Kerur, Karoline Fiedler, Marisa Stahl, Jeffrey Hyams, Michael Stephens, Ying Lu, Marian Pfefferkorn, Raza Alkhouri, Jennifer Strople, Judith Kelsen, Leah Siebold, Alka Goyal, Joel R. Rosh, Neal LeLeiko, Johan Van Limbergen, Anthony L. Guerrerio, Ross M. Maltz, Lina Karam, Eileen Crowley, Anne M. GriffithsMelvin B. Heyman, Mark Deneau, Keith Benkov, Joshua Noe, Dedrick Moulton, Helen Pappa, Joseph Galanko, Scott Snapper, Aleixo M. Muise, Michael D. Kappelman, Eric I. Benchimol
Dive into the research topics of 'Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America'. Together they form a unique fingerprint.